{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:23:21Z","timestamp":1784816601089,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23792347"],"award-info":[{"award-number":["23792347"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25861940"],"award-info":[{"award-number":["25861940"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aobjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Oral Biology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.archoralbio.2014.09.012","type":"journal-article","created":{"date-parts":[[2014,10,18]],"date-time":"2014-10-18T22:04:21Z","timestamp":1413669861000},"page":"557-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Zoledronate inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation via suppression of expression of nuclear factor of activated T-cell c1 and carbonic anhydrase 2"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0603-8264","authenticated-orcid":false,"given":"Takayuki","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kubozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Takechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.archoralbio.2014.09.012_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0010","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","article-title":"Protein geranylgeranylation Is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298","volume":"15","author":"Coxon","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0020","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E","article-title":"The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis","volume":"44","author":"Frith","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0025","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","volume":"7","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2010.05768.x","article-title":"Bisphosphonate-related osteonecrosis of the jaw an overview","volume":"1218","author":"Ruggiero","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on Denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0075","doi-asserted-by":"crossref","first-page":"E437","DOI":"10.1016\/j.oooo.2012.01.046","article-title":"Review of current literature and implications of RANKL inhibitors for oral health care providers","volume":"116","author":"Epstein","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0085","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.intimp.2010.03.008","article-title":"Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate treated monocytes","volume":"10","author":"Marcuzzi","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0090","first-page":"2708","article-title":"Alendomate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway","volume":"62","author":"Virtanen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FPC.0b013e328335729c","article-title":"Bisphosphonates pathway","volume":"21","author":"Gong","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0100","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1248\/bpb.32.1193","article-title":"Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss","volume":"32","author":"Kwak","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.3260404","article-title":"Identification of a putative regulator of early T cell activation genes","volume":"241","author":"Shaw","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0110","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1111\/j.1749-6632.2011.06373.x","article-title":"New regulation mechanisms of osteoclast differentiation","volume":"1240","author":"Nakashima","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0115","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1073\/pnas.0406874102","article-title":"Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium\/calcineurin\/NFAT pathway in osteoclasts","volume":"102","author":"Komarova","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0120","doi-asserted-by":"crossref","first-page":"41147","DOI":"10.1074\/jbc.M205063200","article-title":"Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator","volume":"277","author":"Ishida","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0125","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0130","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.febslet.2009.06.047","article-title":"Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation","volume":"583","author":"Song","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/excr.1998.4071","article-title":"Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+","volume":"242","author":"Lehenkari","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0140","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1073\/pnas.80.9.2752","article-title":"Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification","volume":"80","author":"Sly","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0145","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.lfs.2006.12.037","article-title":"Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells","volume":"80","author":"Fujisaki","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jcp.1099","article-title":"Carbonic anhydrase II is an AP-1 target gene in osteoclasts","volume":"88","author":"David","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4161\/sgtp.2.3.16453","article-title":"The regulation of osteoclast function and bone resorption by small GTPases","volume":"2","author":"Itzstein","year":"2011","journal-title":"Small GTPases"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0160","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1359\/jbmr.1999.14.5.722","article-title":"The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: a clue to the mechanism of action of nitrogen-containing bisphosphonates","volume":"14","author":"Van Beek","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0165","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1359\/jbmr.091114","article-title":"Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis","volume":"25","author":"Leung","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.archoralbio.2014.09.012_bib0170","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1172\/JCI39650","article-title":"Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL\/M-CSF signaling and osteoclast polarization","volume":"120","author":"Ito","year":"2010","journal-title":"J Clin Invest"}],"container-title":["Archives of Oral Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003996914002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003996914002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T02:55:45Z","timestamp":1717469745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003996914002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0003996914002532"],"URL":"https:\/\/doi.org\/10.1016\/j.archoralbio.2014.09.012","relation":{},"ISSN":["0003-9969"],"issn-type":[{"value":"0003-9969","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zoledronate inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation via suppression of expression of nuclear factor of activated T-cell c1 and carbonic anhydrase 2","name":"articletitle","label":"Article Title"},{"value":"Archives of Oral Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archoralbio.2014.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}